NYSE · Medical - Distribution
Prestige Consumer Healthcare Inc. (PBH) Stock
$48.23
+0.75%
NYSE: PBH
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Is the Options Market Predicting a Spike in Prestige Consumer Healthcare Stock?
Zacks · Jul 6, 2026
Prestige Consumer Healthcare Inc. Completes Acquisition of LaCorium Health, Prices $400 Million Senior Notes Offering, and Announces First Quarter Fiscal 2027 Earnings Results Date
GlobeNewswire · Jul 6, 2026
Prestige Consumer Healthcare Inc. (PBH): A Top Ariel Investments Stock to Buy Following Breathe Right Brand Acquisition
Insider Monkey · Jul 4, 2026
Alphabet Joined the Dow and Became a Top Holding in Berkshire Hathaway's Portfolio. But This Stock Could Be an Even Better Buy.
Motley Fool · Jul 3, 2026
Prestige Plans $400 Million Private Offering of Senior Notes
MT Newswires · Jun 30, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held1.38%
Institutions Held113.97%
Institutions Float Held115.56%
Peer Comparison
About Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare Inc. (PBH) stock trades at $48.23 with a market capitalization of $2.28B. The stock is valued at a price-to-earnings (P/E) ratio of 12.61, price-to-book of 1.12, price-to-sales of 1.94. Over the past 52 weeks the stock has ranged between $42.62 and $71.07, and currently trades 32.1% below its 52-week high.
On profitability, Prestige Consumer Healthcare Inc. generates a return on equity (ROE) of 9.22%, return on capital employed of 6.57%, an operating margin of 28.37%, a net profit margin of 15.57%.